home / stock / veru / veru news

VERU News and Press, Veru Inc. From 01/25/24

Stock Information
Company Name: Veru Inc.
Stock Symbol: VERU
Market: NASDAQ
Website: verupharma.com
Menu
VERU VERU Quote VERU Short VERU News VERU Articles VERU Message Board
Get VERU Alerts

News, Short Squeeze, Breakout and More Instantly...
VERU - Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

MIAMI, FL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of obesity, oncology, and viral induced acute respiratory distress syndrome, today announced it will host a conference cal...
VERU - Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

MIAMI, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of obesity, oncology, and viral induced acute respiratory distress syndrome, today announced submission of an Investigatio...

VERU - Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs

MIAMI, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of obesity, oncology, and viral induced acute respiratory distress syndrome, today announced it will host an investor conf...

VERU - Expected US Company Earnings on Monday, December 18th, 2023

Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...
VERU - Veru stock falls after it prices its public offering at $0.72 per share

2023-12-14 09:17:00 ET More on Veru Veru to conduct Phase2b study with enobosarm, GLP-1 weight-loss drugs For further details see: Veru stock falls after it prices its public offering at $0.72 per share

VERU - Veru announces proposed public offering of common stock

2023-12-13 16:06:46 ET More on Veru Veru to conduct Phase2b study with enobosarm, GLP-1 weight-loss drugs Seeking Alpha’s Quant Rating on Veru Historical earnings data for Veru Financial information for Veru For further details see: Veru an...

VERU - GTHX, MRKR and CLIR among mid-day movers

2023-12-11 12:51:49 ET Gainers: Jet.AI ( JTAI ) +70% . Boqii Holding Limited ( BQ ) +34% . Marker Therapeutics ( MRKR ) +34% . Morphosys AG ( MOR ) +25% . G1 Therapeutics ( GTHX ) +24% . Innoviz Technologies Ltd ( INVZ ) ...
VERU - Veru, Kodiak Sciences among healthcare movers

2023-12-11 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Veru, Kodiak S...

VERU - PPBT, ANY and FLJ among pre-market losers

2023-12-11 08:27:31 ET Losers: Cogent Biosciences ( COGT ) -31% . announces positive data from ongoing phase 2 APEX trial evaluating Bezuclastinib in patients . Purple Biotech Ltd ( PPBT ) -16% . Sphere 3D Corp ( ANY ) -14% . FLJ Group Ltd ( F...

VERU - Expected US Company Earnings on Monday, December 11th, 2023

Lanvin Group Holdings Limited (LANV) is expected to report for quarter end 2023-09-30 Sonnet BioTherapeutics Holdings Inc. (SONN) is expected to report for Q4 2023 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q2 2024 Gelesis Holdings, Inc. (GLSHQ) is expected to repor...
Previous 10 Next 10